Finance

Beta
Ask
Lists
1789:TPE
ScinoPharm Taiwan Ltd
NT$19,90
+1,53%
(+0,30) 1D
12 Jun., 13:30:07 GMT+8  ·   TWD
All symbols
SymbolPriceChange% Change
Generating top insights for 1789...
Open
NT$20,15
High
NT$20,15
Low
NT$19,60
Mkt. cap
15,74 mjd
Avg. vol.
887,52 k
Volume
949,01 k
Dividend
1,46%
Quarterly dividend
NT$0,07
Ex-dividend date
02 Jul. 2026
P/E ratio
146,61
52-wk high
NT$29,10
52-wk low
NT$16,25
EPS
NT$0,14
Shares outstanding
790,74 m
No. of employees
1 k
Open
NT$20,15
High
NT$20,15
Low
NT$19,60
Mkt. cap
15,74 mjd
Avg. vol.
887,52 k
Volume
949,01 k
Dividend
1,46%
Quarterly dividend
NT$0,07
Ex-dividend date
02 Jul. 2026
P/E ratio
146,61
52-wk high
NT$29,10
52-wk low
NT$16,25
EPS
NT$0,14
Shares outstanding
790,74 m
No. of employees
1 k
News stories
From sources across the web
About ScinoPharm Taiwan Ltd
CEO-
Employees1,01 k
Founded11 Nov. 1997
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in TWD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in TWD
Jun. 2025
Sep. 2025
Des. 2025
Mrt. 2026
Revenue
747,52 m
721,50 m
1,01 mjd
659,71 m
Cost of goods sold
427,98 m
505,66 m
674,97 m
438,17 m
Cost of revenue
427,98 m
505,66 m
674,97 m
438,17 m
Research and development expenses
113,47 m
121,40 m
195,17 m
85,54 m
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
125,79 m
114,03 m
128,12 m
112,89 m
Operating expense
239,27 m
235,45 m
325,04 m
213,05 m
Total operating expenses
667,26 m
741,11 m
1,00 mjd
651,22 m
Operating income
80,26 m
-19,62 m
8,03 m
8,49 m
Other non operating income
16,27 m
-9,89 m
19,92 m
778,00 k
EBT including unusual items
46,69 m
19,18 m
23,96 m
19,32 m
EBT excluding unusual items
46,46 m
19,28 m
21,96 m
19,32 m
Income tax expense
12,49 m
3,73 m
-17,32 m
2,80 m
Effective tax rate
26,75%
19,46%
-72,27%
14,47%
Other operating expenses
-
-
-
-
Net income
34,20 m
15,45 m
41,28 m
16,53 m
Net profit margin
4,58%
2,14%
4,10%
2,51%
Earnings per share
0,04
0,02
0,05
-
Interest and investment income
13,34 m
37,62 m
-
13,03 m
Interest expense
-2,27 m
-2,71 m
-16,12 m
-2,97 m
Net interest expenses
11,07 m
34,92 m
-16,12 m
10,06 m
Depreciation and amortization charges
-
-
-
-
EBITDA
202,53 m
105,83 m
134,08 m
139,35 m
Gain or loss from assets sale
-172,00 k
100,00 k
188,00 k
21,00 k
AI content may include mistakes. Learn more
AI content may include mistakes. Learn more